Accounts Payable and Accrued Expenses

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Accounts Payable and Accrued Expenses

6. Accounts Payable and Accrued Expenses:

Accounts payable and accrued expenses consist of the following (in thousands):

	March 31, 2024	December 31, 2023
Accounts payable	$31,636	$34,588
Accrued salaries and incentive compensation	65,711	193,112
Accrued payroll taxes and benefits	23,674	36,545
Accrued professional liabilities	29,034	32,039
Accrued interest	2,936	8,262
Other accrued expenses	54,044	46,252
	$207,035	$350,798

The net decrease in accrued salaries and incentive compensation of $127.4 million, from December 31, 2023 to March 31, 2024, is primarily due to the payment of performance-based incentive compensation, principally to the Company’s affiliated physicians, partially offset by performance-based incentive compensation accrued during the three months ended March 31, 2024. A majority of the Company’s payments for performance-based incentive compensation is paid annually during the first quarter.